Literature DB >> 10649686

The effect of N-acetylglucosamine as a substrate for in vitro synthesis of glycosaminoglycans by human peritoneal mesothelial cells and fibroblasts.

A Breborowicz1, M Kuzlan-Pawlaczyk, K Wieczorowska-Tobis, J Wisniewska, P Tam, I French, G Wu.   

Abstract

The effect of N-acetylglucosamine (NAG) on in vitro synthesis of glycosaminoglycans by human peritoneal mesothelial cells and fibroblasts was studied. In contrast to isosmotic concentrations of glucose, NAG increases the synthesis of hyaluronan by mesothelial cells and fibroblasts in a dose-dependent manner. This effect of NAG can be demonstrated in the presence of increased glucose levels in a medium, or in a medium mixed with effluent dialysate obtained from continuous ambulatory peritoneal dialysis (CAPD) patients. Glucose inhibits synthesis of sulphated glycosaminoglycans by peritoneal mesothelial cells and fibroblasts, whereas NAG stimulates their production. Our results demonstrate that NAG is an effective stimulator of the in vitro glycosaminoglycans synthesis by human peritoneal mesothelial cells and fibroblasts.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 10649686

Source DB:  PubMed          Journal:  Adv Perit Dial        ISSN: 1197-8554


  3 in total

1.  Chondroprotective activity of N-acetylglucosamine in rabbits with experimental osteoarthritis.

Authors:  A R Shikhman; D Amiel; D D'Lima; S-B Hwang; C Hu; A Xu; S Hashimoto; K Kobayashi; T Sasho; M K Lotz
Journal:  Ann Rheum Dis       Date:  2005-01       Impact factor: 19.103

2.  A New HPLC-ELSD Method for Simultaneous Determination of N-Acetylglucosamine and N-Acetylgalactosamine in Dairy Foods.

Authors:  Ho Jin Kim; In Kyung Bae; Min Hee Jeong; Hye Jin Park; Jin Sil Jung; Jang Eok Kim
Journal:  Int J Anal Chem       Date:  2015-12-15       Impact factor: 1.885

Review 3.  Animal Models of Peritoneal Dialysis: Thirty Years of Our Own Experience.

Authors:  Krzysztof Pawlaczyk; Ewa Baum; Krzysztof Schwermer; Krzysztof Hoppe; Bengt Lindholm; Andrzej Breborowicz
Journal:  Biomed Res Int       Date:  2015-07-06       Impact factor: 3.411

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.